Venlafaxine Treatment of Patients With Comorbid Alcohol/Cocaine Abuse and Attention-Deficit/Hyperactivity Disorder: A Pilot Study
Authors:
- Himanshu P. UpadhyayaHUHimanshu P. Upadhyaya
- Kathleen T. BradyKBKathleen T. Brady
- Gopalan SethuramanGSGopalan Sethuraman
- Susan C. SonneSSSusan C. Sonne
- Robert MalcolmRMRobert Malcolm
- 1 February 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 21 (1) , 116-118
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Attention-deficit hyperactivity disorder and comorbid substance use disorders in adultsPsychiatric Services, 1995
- Attention-Deficit Hyperactivity Disorder and Substance Abuse: Relationships and Implications for TreatmentHarvard Review of Psychiatry, 1995
- Pharmacology of Antidepressants—Characteristics of the Ideal DrugMayo Clinic Proceedings, 1994
- A Comparison of Venlafaxine, Trazodone, and Placebo in Major DepressionJournal of Clinical Psychopharmacology, 1994
- The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder [published erratum appears in Am J Psychiatry 1993 Aug;150(8):1280]American Journal of Psychiatry, 1993
- Reliability of a Timeline Method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populationsBritish Journal of Addiction, 1988
- Methylphenidate for depressionAmerican Journal of Psychiatry, 1983
- Pemoline in attention deficit disorder and alcoholism: a case studyAmerican Journal of Psychiatry, 1983